Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F(ab)2 anti-carcinoembryonic antigen MAb and AHSCR

Journal of Nuclear Medicine

Volumn 41, Issue 1, 2000, Pages 93-103

  Juweid, Malik E ^a   Hajjar, George ^b   Stein, Rhona ^b   Sharkey, Robert M ^b   Herskovic, Thomas ^b   Swayne, Lawrence C ^b   Suleiman, Samer ^b   Pereira, Michael ^b   Rubin, Arnold D ^b   Goldenberg, David M ^b  

^a GARDEN STATE CANCER CENTER   (United States)

^b NONE

Author keywords

Carcinoembryonic antigen; Medullary thyroid cancer; Monoclonal antibodies; Radioimmunotherapy

Indexed keywords

CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; IODINE 131;

ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; CLINICAL ARTICLE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIOIMMUNOTHERAPY; THYROID CANCER; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOMA, MEDULLARY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RADIOIMMUNOTHERAPY; RADIOTHERAPY DOSAGE; THYROID NEOPLASMS;

EID: 0033984384     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Norton JA, Levin B, Jensen R. Cancer of the endocrine system. In: DeVita VT, Hellman S, Rosen SA, eds. Cancer: Principles and Practices of Oncology. New York, NY: JB Lippincott; 1989:1333-1435.
2. Cance WG, Wells SA Jr. Multiple endocrine neoplasia type IIa. Curr Probl Surg. 1985;22:1-56.
3. Tubiana M, Haddad E, Schlumberger M, et al. External radiotherapy in thyroid cancer. Cancer. 1985;55:2062-2071.
4. Wells SA Jr., Dilley WG, Farndon JA, Leight GS, Baylin SB. Early diagnosis and treatment of medullary carcinoma. Arch Intern Med. 1985;145:1248-1252.
5. Busnardo B, Girelli ME, Simioni N, Macamulli D, Busetto E. Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma. Cancer. 1984;53:278-285.
6. Ishikawa N, Hamada S. Association of medullary carcinoma of the thyroid with carcinoembryonic antigen. Br J Cancer. 1976;34:111-115.
7. 131I-labeled monoclonal antibodies to carcinoembryonic antigen. Cancer Res. 1995;55(suppl):5946S-5951S.
8. Juweid ME, Sharkey RM, Behr T, et al. Improved detection of medullary thyroid cancer with radiolabeled antibodies to carcinoembryonic antigen. J Clin Oncol. 1996;14:1209-1217.
9. Press OW, Eary JF, Appelbaum FR, et al. Radiolabeled antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med. 1993;329:1219-1224.
10. Hansen HJ, Goldenberg DM, Newman ES, Grebenau R, Sharkey RM. Characterization of second-generation monoclonal antibodies against carcinoembryonic antigen. Cancer. 1993;71:3478-3485.
11. 2. Cancer. 1996;78:157-168.
12. Hoffman T. Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use. Rockville, MD: Office of Biologics Research and Review, Center for Drugs and Biologics, Food and Drug Administration; 1987.
13. Weadock KS, Sharkey RM, Varga DC, Goldenberg DM. Evaluation of a remote radioiodination system for radioimmunotherapy. J Nucl Med. 1990;31:508-511.
14. 131I-labeled anti-carcinoembryonic antigen monoclonal antibody. Cancer Res. 1990;50(suppl):1039S-1042S.
15. Siegel JA, Goldenberg DM, Sharkey RM, Hall TC, Murthy S, Lee RE. Tumor and organ dosimetry for I-131-labeled LL2 (EPB2) monoclonal antibody in patients with B-cell lymphomas. Antibiot Immunoconj Radiopharm. 1990;4:649-654.
16. Loevinger R, Berman M. A Revised Scheme for Calculating the Absorbed Dose from Biologically Distributed Radionuclide. MIRD Pamphlet No. I. New York, NY: Society of Nuclear Medicine; 1976.
17. Sgouros G. Bone marrow dosimetry for radioimmunotherapy: theoretical considerations. J Nucl Med. 1993;34:689-694.
18. 90Y-Mx-diethylenetriaminepentaacetic acid (DTPA)-BrE3 and autologous hematopoietic stem cell support for the treatment of advanced breast cancer: a phase I trial. Cancer Res. 1995;55(suppl): 5921S-5924S.
19. 131I-labeled chimerac L6 antibody with peripheral blood progenitor cell transfusions. Cancer Res. 1995; 55(suppl):5916S-5920S.
20. 131I-conjugated monoclonal antibody CC49: a phase I trial [abstract]. Antibiot Immunoconj Radiopharm. 1993;6:90.
21. 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B-cell lymphomas. Lancet. 1995;346:336-340.
22. Sharkey RM, Juweid ME, Shevitz J, et al. Evaluation of a complementarity-determining region-grafted (humanized) anti-carcinoembryonic antigen monoclonal antibody in preclinical and clinical studies. Cancer Res. 1995;55(suppl):5935S-5945S.